EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders

Matthew J Y Kang iD, Dhamidhu Eratne iD, Hannah Dobson iD, Charles B Malpas iD, Michael Keem, Courtney Lewis, Jasleen Grewal, Vivian Tsoukra, Christa Dang iD, Ramon Mocellin, Tomas Kalincik iD, Alexander F Santillo iD und 14 weitere

Acta Neuropsychiatrica · 2024-02 · 36 (1) · 17-28

DOI: 10.1017/neu.2023.25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropsychiatrica, online erschienen am 28.04.2023. Verfasst von Matthew J Y Kang und 25 weiteren Autor:innen. Beteiligte Einrichtung: Neuropsychiatry, Royal Melbourne Hospital, Parkville, VIC, Australia. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases, Cognitive Dysfunction. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

People with neuropsychiatric symptoms often experience delay in accurate diagnosis. Although cerebrospinal fluid neurofilament light (CSF NfL) shows promise in distinguishing neurodegenerative disorders (ND) from psychiatric disorders (PSY), its accuracy in a diagnostically challenging cohort longitudinally is unknown.

Methods

We collected longitudinal diagnostic information (mean = 36 months) from patients assessed at a neuropsychiatry service, categorising diagnoses as ND/mild cognitive impairment/other neurological disorders (ND/MCI/other) and PSY. We pre-specified NfL > 582 pg/mL as indicative of ND/MCI/other.

Results

Diagnostic category changed from initial to final diagnosis for 23% (49/212) of patients. NfL predicted the final diagnostic category for 92% (22/24) of these and predicted final diagnostic category overall (ND/MCI/other vs. PSY) in 88% (187/212), compared to 77% (163/212) with clinical assessment alone.

Conclusions

CSF NfL improved diagnostic accuracy, with potential to have led to earlier, accurate diagnosis in a real-world setting using a pre-specified cut-off, adding weight to translation of NfL into clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeurodegenerative DiseasesCognitive DysfunctionHumansNeurofilament ProteinsIntermediate FilamentsBiomarkers

Stichwörter der Autor:innen

biomarkerdementiadiagnosisdiagnostic delayneurofilamentneuropsychiatrypsychiatric disorders

Substanzen

Neurofilament ProteinsBiomarkers

Autor:innen und Institutionen

  • Neuropsychiatry, Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Melbourne Neuropsychiatry Centre & Department of Psychiatry, University of Melbourne, Parkville, VIC, Australia.
  • Alfred Mental and Addiction Health, Alfred Health, Melbourne, VIC, Australia.
  • Department of Medicine, Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Melbourne School of Psychological Sciences, University of Melbourne, Parkville, VIC, Australia.
  • Department of Neurology, Evangelismos Hospital, Athens, Greece.

ORCID-Profile: Matthew J Y Kang, Dhamidhu Eratne, Hannah Dobson, Charles B Malpas, Christa Dang, Tomas Kalincik, Alexander F Santillo, Henrik Zetterberg, Kaj Blennow, Christiane Stehmann, Qiao-Xin Li, Colin L Masters, Steven Collins, Samuel F Berkovic, Andrew Evans, Sarah Farrand, Samantha M Loi, Mark Walterfang

Zitieren

APA

Kang, M. J. Y., Eratne, D., Dobson, H., Malpas, C. B., Keem, M., Lewis, C., Grewal, J., Tsoukra, V., Dang, C., Mocellin, R., Kalincik, T., Santillo, A. F., Zetterberg, H., Blennow, K., Stehmann, C., Varghese, S., Li, Q. X., Masters, C. L., Collins, S., …, & Velakoulis, D. (2024). Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders. Acta Neuropsychiatrica, 36(1), 17-28. https://doi.org/10.1017/neu.2023.25

Vancouver

Kang MJY, Eratne D, Dobson H, Malpas CB, Keem M, Lewis C, et al. Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders. Acta Neuropsychiatrica. 2024;36(1):17-28. doi:10.1017/neu.2023.25

BibTeX
@article{Kang2024,
  author = {Kang, Matthew J Y and Eratne, Dhamidhu and Dobson, Hannah and Malpas, Charles B and Keem, Michael and Lewis, Courtney and Grewal, Jasleen and Tsoukra, Vivian and Dang, Christa and Mocellin, Ramon and Kalincik, Tomas and Santillo, Alexander F and Zetterberg, Henrik and Blennow, Kaj and Stehmann, Christiane and Varghese, Shiji and Li, Qiao-Xin and Masters, Colin L and Collins, Steven and Berkovic, Samuel F and Evans, Andrew and Kelso, Wendy and Farrand, Sarah and Loi, Samantha M and Walterfang, Mark and Velakoulis, Dennis},
  title = {Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders},
  journal = {Acta Neuropsychiatrica},
  year = {2024},
  volume = {36},
  number = {1},
  pages = {17--28},
  doi = {10.1017/neu.2023.25}
}
Kostenlos starten →